Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal)

Technology appraisal
Reference number: TA206
Published: 27 October 2010

History

Background information

Lymphoma (non-Hodgkin's) - bendamustine (terminated appraisal): press release information
2010/153 NICE publishes guidance on three cancer drugs (PDF 73 KB)

Published:

06 December 2013

Lymphoma (non-Hodgkin's) - bendamustine: provisional matrix

Lymphoma (non-Hodgkin's) - bendamustine: provisional matrix (PDF 59 KB)

Published:

28 May 2010

Lymphoma (non-Hodgkin's) - bendamustine: draft scope for consultation

Lymphoma (non-Hodgkin's) - bendamustine: draft scope for consultation (PDF 76 KB)

Published:

28 May 2010